Hypophosphatemia: Clinical consequences and management

Journal of the American Society of Nephrology

Volumn 18, Issue 7, 2007, Pages 1999-2003

  Brunelli, Steven M ^a,b   Goldfarb, Stanley ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Blackley Hall   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PHOSPHATE; POTASSIUM DIHYDROGEN PHOSPHATE; SODIUM DIHYDROGEN PHOSPHATE;

ALCOHOLISM; ARTIFICIAL VENTILATION; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; CRITICALLY ILL PATIENT; CRYOSURGERY; DIABETIC KETOACIDOSIS; DIALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HEMOLYTIC ANEMIA; HOSPITAL PATIENT; HUMAN; HYPOPHOSPHATEMIA; INCIDENCE; INJURY; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER RESECTION; MORTALITY; NUTRITIONAL STATUS; OUTCOMES RESEARCH; OUTPATIENT; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVIEW; RHABDOMYOLYSIS; SEPSIS; SURGICAL PATIENT; TREATMENT OUTCOME;

EID: 34447268723     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007020143     Document Type: Review

References (47)

1. Gaasbeek A, Meinders E: Hypophosphatemia: An update on its etiology and treatment. Am J Med 118: 1094-1101, 2005
2. Jacob HS, Amsden T: Acute hemolytic anemia with rigid cells in hypophosphatemia. N Engl J Med 290: 385: 1446-1450, 1971
3. Nakao M, Nakao T, Yamazoe S, Yoshikawa H: Adenosine triphosphate and shape of erythrocytes. J Biochem 49: 487-492, 1961
4. Nakao M, Nakao T, Yamazoe S: Adenosine triphosphate and maintenance of shape of the human red cells. Nature 187: 945-946, 1960
5. LaCelle PL: Alteration of membrane deformability in hemolytic anemias. Semin Hematol 7: 355-371, 1970
6. Knochel JP, Bilbrey GL, Fuller TJ, Carter NW: The muscle cell in chronic alcoholism. The possible role of phosphate depletion in alcoholic myopathy. Ann N Y Acad Sci 252: 274-286, 1975
7. Fisher JN, Kitabchi AE: A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57: 177-180, 1983
8. Darsee JR, Nutter DO: Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia. Ann Intern Med 89: 867-870, 1978
9. Davis SV, Olichwier KK, Chakko SC: Reversible depression of myocardial performance in hypophosphatemia. Am J Med Sci 295: 183-187, 1988
10. Vered I, Vered Z, Perez JE, Jaffe AS, Whyte MP: Normal left ventricular performance in children with X-linked hypophosphatemic rickets: A Doppler echocardiography study. J Bone Miner Res 5: 469-474, 1990
11. DeFronzo RA, Lang R: Hypophosphatemia and glucose intolerance: Evidence for tissue insensitivity to insulin. N Engl J Med 303: 1259-1263, 1980
12. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A: Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 60: 734-739, 2006
13. Lind L, Lithell H, Hvarfner A, Pollare T, Ljunghall S: On the relationship between mineral metabolism, obesity and fat distribution. Eur J Clin Invest 23: 307-310, 1993
14. Haglin L, Lindblad A, Bygren LO: Hypophosphatemia in the metabolic syndrome. Gender difference in body weight and blood glucose. Eur J Clin Nutr 55: 493-498, 2001
15. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M: Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325: 1843-1848, 1991
16. Makitie O, Doria S, Kooh SW, Cole WG, Daneman A, Sochett E: Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88: 3591-3597, 2003
17. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005
18. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
19. Slinin Y, Foley R, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005
20. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005
21. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
22. Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SA, Juppner H, Wolf M: Post-transplant hypophosphatemia: Tertiary hyper-phosphatoninism? Kidney Int 70: 1486-1494, 2006
23. Levi M: Post-transplant hypophosphatemia. Kidney Int 59: 2377-2387, 2001
24. Ghanekar H, Welch BJ, Moe OW, Sakhaee K: Post-renal transplantation hypophosphatemia: A review and novel insights. Curr Opin Nephrol Hypertens 15: 97-104, 2006
25. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM: Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14: 456-463, 1999
26. Vautour LM, Melton LJ, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT: Long-term fracture risk following renal transplantation: A population-based study. Osteoporos Int 15: 160-167, 2004
27. Ponce P, Gusmao L, Adrago T, Bruges M, Gomes EM, Antunes J: Consequences of the correction of post-transplantation hypophosphatemia on mineral metabolism. Acta Med Port 7: 207-210, 1994
28. Shiber JR, Mattu A: Serum phosphate abnormalities in the emergency department. J Emerg Med 23: 395-400, 2002
29. Shackney S, Hasson J: Precipitous fall in serum calcium, hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia. Ann Intern Med 66: 906-916, 1967
30. Winter RJ, Harris CJ, Phillips LS, Green OC: Diabetic ketoacidosis: Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 67: 897-900, 1979
31. Chernow B, Rainey TG, Geroges LP, O'Brien JT: Iatrogenic hyperphosphatemia: A metabolic consideration in critical care medicine. Crit Care Med 9: 772-774, 1981
32. Vannatta JB, Anderss DL, Whang R, Papper S: High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia. South J Med 76: 1424-1426, 1983
33. Rosen GH, Boullata JI, O'Rangers EA, Enow NB, Shin B: Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med 23: 1204-1210, 1995
34. Clark CL, Sacks GS, Dickerson RN, Kudsk KA, Brown RO: Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: Results from a prospective clinical trial. Crit Care Med 23: 1504-1511, 1995
35. Zazzo JF, Troche G, Ruel P, Maintenant J: High incidence of hypophosphatemia in surgical intensive care patients: Efficacy of phosphorus therapy on myocardial function. Intensive Care Med 21: 826-831, 1995
36. Charron T, Bernard F, Skrobik Y, Simoneau N, Gagnon N, Leblanc M: Intravenous phosphate in the intensive care unit: More aggressive repletion regimens for moderate and severe hypophosphatemic. Intensive Care Med 29: 1273-1278, 2003
37. Taylor BE, Huey WY, Buchman TG, Boyle WA, Coopersmith CM: Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit. J Am Coll Surg 198: 198-204, 2004
38. Kagansky N, Levy S, Koren-Morag N, Berger D, Knobler H: Hypophosphatemia in old patients is associated with the refeeding syndrome and reduced survival. J Intern Med 257: 461-468, 2005
39. Camp MA, Allon M: Severe hypophosphatemia in hospitalized patients. Miner Electrolyte Metab 16: 365-368, 1990
40. Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, Fux A, Boaz M, Weinstein J: Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 36: 67-72, 2006
41. Gravelyn TR, Brophy N, Seigert C, Peters-Golden M: Hypophosphatemia- associated respiratory muscle weakness in a generalized inpatient population. Am J Med 84: 870-876, 1988
42. Marik PE, Bedigian MK: Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study. Arch Surg 131: 1043-1047, 1996
43. Bollaert P, Levy B, Nace L, Laterre P, Larcan A: Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 107: 1698-1701, 1995
44. Giovannini I, Chiarla C, Nuzzo G: Pathophysiologic and clinical correlates of hypophosphatemia and the relationship with sepsis and outcome in postoperative patients after hepatectomy. Shock 18: 111-115, 2002
45. George R, Shiu MH: Hypophosphatemia after major hepatic resection. Surgery 111: 281-286, 1992
46. Aubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, Pariente R: Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 313: 420-424, 1985
47. Ognibene A, Ciniglio R: Ventricular tachycardia in acute myocardial infarction: The role of hypophosphatemia. South Med J 87: 65-69, 1994